|
Match
|
Document |
Document Title |
|
|
US20150071880 |
TREATMENT OF EPITHELIAL LAYER LESIONS
Methods for the treatment of lesions originating in an epithelial layer, particularly diseases of the epithelium of the skin, bladder, oral mucosa, vagina and cervix are described. Also described... |
|
|
US20150010509 |
CALCIUM FOLATE (CAFOLATE) AND THERAPEUTIC METHODS BASED THEREON
Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the... |
|
|
US20120251495 |
PTERIN BASED THERAPIES FOR INFLAMMATORY CONDITIONS
Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection based upon the administration of calcium pterin. In one... |
|
|
US20150071992 |
CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The... |
|
|
US20110014247 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral... |
|
|
US20110142800 |
METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, methods for treating diabetes mellitus, comprising administering same, and methods for oral... |
|
|
US20110165124 |
METHODS FOR DIAGNOSING OR PREDICTING HEPATITIS C OUTCOME IN HCV INFECTED PATIENTS
The present invention relates to in vitro methods of determining a susceptibility to non-response to a hepatitis C treatment or a susceptibility to spontaneous hepatitis C clearance in a subject... |
|
|
US20150098926 |
Methods of Treating Hepatitis C Virus Infection
The present invention provides methods of treating hepatitis C virus (HCV) infection; methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver; and methods... |
|
|
US20110243894 |
METHODS OF TREATING HEPATITIS C VIRUS INFECTION
The present invention provides methods of treating hepatitis C virus (HCV) infection; methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver; and methods... |
|
|
US20150126402 |
Method for Quantifying Proteins and Isoforms Thereof
A method for quantifying metallothionein protein isomers is described herein. Such metallothionein isomer protein quantification is useful for detecting and monitoring disease. As illustrated... |
|
|
US20110184379 |
METHOD AND SYSTEM TO DEFINE PATIENT SPECIFIC THERAPEUTIC REGIMENS BY MEANS OF PHARMACOKINETIC AND PHARMACODYNAMIC TOOLS
Methods for treating Hepatitis infections are provided. In one embodiment, an initial dosage of interferon is administered to a patient, and interferon serum levels and viral load data is... |
|
|
US20150218649 |
BIOMARKER ASSOCIATED WITH RISK OF MELANOMA REOCCURRENCE
The present invention provides a method of predicting the risk of reoccurrence of melanoma in a patient from whom melanoma tissue was previously removed which comprises the following: a. obtaining... |
|
|
US20140010781 |
SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER
The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus... |
|
|
US20110293565 |
NOVEL SYNTHETIC AGONISTS OF TLR9
The invention relates to synthetic chemical compositions that are useful for modulation of Toll-Like Receptor (TLR)-mediated immune responses. In particular, the invention relates to agonists of... |
|
|
US20130129670 |
MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS
The present invention relates to Macrophage Activating Factors such as GcMAF and compositions thereof, for use in the treatment of a patient suffering from CFS/ME and/or XMRV infection. |
|
|
US20100310469 |
VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of natural cytokine mixture (NCM), an effective amount of cyclophosphamide... |
|
|
US20120100102 |
CANCER VACCINE
We disclose a vaccine comprising a pappalysin and vaccine compositions comprising a pappalysin. |
|
|
US20110033422 |
TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION
The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. |
|
|
US20130195794 |
CANCER VACCINE
The disclosure relates to a vaccine including at least one adjuvant useful in the prevention and treatment of blood cancers, for example lymphoma, leukaemia or myeloma. |
|
|
US20120225029 |
Skin Cream
The present invention relates to skin care compositions, including cosmeceuticals, for topical application, and more particularly, a skin cream, comprising cell culture medium conditioned by cells... |
|
|
US20140086872 |
Methods of Treating a Subject for a Condition
Methods are provided for treating a subject for at least one condition that includes inflammation, a blood clotting condition and autonomic nervous system dysfunction such as adrenergia, e.g.,... |
|
|
US20110212136 |
Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury
A formulation including injectable biodegradable nanospheres and/or microspheres as a delivery system for chondroitinase ABC (cABC) or a functional derivative of cABC to treat acute and chronic... |
|
|
US20130295043 |
VACCINATION IN ELDERLY PATIENTS
The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in an elderly patient preferably exhibiting an age of at... |
|
|
US20150023912 |
COMBINATIONS OF ALBUMIN-BASED DRUG DELIVERY SYSTEMS
The present invention relates to a composition comprising at least two different albumin-based drug delivery systems, as well as to a pharmaceutical composition comprising said composition. |
|
|
US20140271546 |
GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma. |
|
|
US20120039850 |
HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir
The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the... |
|
|
US20110311476 |
Methods For Treating An Immune Deficiency Or Enhancing Immune Function Using Salicinium, Non-Limited In Terms Of Treatment Indication, But Encompassing Methods For Treating Cancer And Microbial, Bacterial, Viral, Fungal; Non-Limited In Terms of Delivery Mode, Formulation
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become... |
|
|
US20150104415 |
Treatments of Hepatitis C virus infection
The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection. |
|
|
US20110250171 |
Compositions and Methods for Cancer Immunotherapy
The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment... |
|
|
US20150044292 |
BIPHASIC LIPID-VESICLE COMPOSITIONS AND METHODS FOR TREATING CERVICAL DYSPLASIA BY INTRAVAGINAL DELIVERY
This invention relates to biphasic lipid-vesicle compositions and methods for treating cervical displasia by intravaginal delivery. |
|
|
US20150044276 |
BIPHASIC LIPID-VESICLE COMPOSITIONS AND METHODS FOR TREATING CERVICAL DYSPLASIA BY INTRAVAGINAL DELIVERY
This invention relates to biphasic lipid-vesicle compositions and methods for treating cervical displasia by intravaginal delivery. |
|
|
US20150044275 |
BIPHASIC LIPID-VESICLE COMPOSITIONS AND METHODS FOR TREATING CERVICAL DYSPLASIA BY INTRAVAGINAL DELIVERY
This invention relates to biphasic lipid-vesicle compositions and methods for treating cervical displasia by intravaginal delivery. |
|
|
US20150044274 |
BIPHASIC LIPID-VESICLE COMPOSITIONS AND METHODS FOR TREATING CERVICAL DYSPLASIA BY INTRAVAGINAL DELIVERY
This invention relates to biphasic lipid-vesicle compositions and methods for treating cervical displasia by intravaginal delivery. |
|
|
US20110311478 |
Combinatorial Methods For Treating Cellular Proliferative Disorders And Immune Deficiencies Using Salicinium
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become... |
|
|
US20150150994 |
LIVER TARGETED DRUG DELIVERY SYSTEMS USING METAL NANOPARTICLES AND PREPARING METHOD THEREOF
The present invention relates to liver targeted drug delivery system using metal nanoparticles and a method for preparing the same. More particularly, the present invention relates to a method for... |
|
|
US20140314715 |
Compositions and Methods for Diagnosing and Treating Sjogren's Syndrome
Methods for detection and diagnosis of Sjögren's Syndrome in a subject, determining the stage or progression of Sjögren's Syndrome in a subject, determining the effectiveness of a treatment for... |
|
|
US20120076837 |
SURFACE ENGINEERING OF TISSUE GRAFT MATERIALS FOR ENHANCED POROSITY AND CELL ADHESION
In one aspect, the invention relates to providing enhanced application tissue graft materials in regenerative medicine through improved cellular interactions. Biocompatible implant materials,... |
|
|
US20110229411 |
USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT
The present invention concerns methods for assessing the sensibility of a subject to an anticancer treatment, for screening compounds which are useful for treating a cancer and for determining the... |
|
|
US20130121964 |
Pharmacogenomic and Response-Guided Treatment of Infectious Disease Using Yeast-Based Immunotherapy
Disclosed are improved methods for treating an infectious disease with yeast-based immunotherapy, including viral disease, such as disease resulting from hepatitis virus infection, using a... |
|
|
US20130209401 |
COMPOSITIONS AND METHODS FOR INHIBITING ENTRY OF A HEPATIC VIRUS
The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection. |
|
|
US20110171177 |
Compositions and Methods for Inhibiting Entry of a Hepatic Virus
The present invention embraces Niemann-Pick C1-like 1 protein antagonists and agents that inhibit hepatic virus infection for use in the prevention and treatment of a hepatic virus infection. |
|
|
US20150139950 |
ALISPORIVIR TO TREAT HEPATITIS C VIRUS INFECTION
The disclosure concerns the use of cyclophilin inhibitors in the treatment of chronic Hepatitis C virus infection. |
|
|
US20110135605 |
METHODS AND PRODUCTS RELATED TO TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION
The invention provides methods for identifying and treating subjects having hepatitis C infections. In some instances, the subjects are those that are non-responsive to non-CpG therapy.... |
|
|
US20130195798 |
COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS
One can treat a viral infection by first administering at least one first antiviral compound for a first time period and then, after the end of the first time period, concurrently or subsequently... |
|
|
US20110059045 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
The invention relates to therapeutic compositions for the treatment of cancer and, more specifically, compositions containing an agonist ligand for receptor 4-1BB and a type-1 interferon, the... |
|
|
US20150044148 |
Method for Treating Capillary Hemangiomas
The invention relates to a method of treating capillary hemangiomas in a human in need thereof by topically administering an effective amount of one or more alpha-2 adrenergic receptors agonist to... |
|
|
US20110033419 |
Methods and Compositions for Treating Cancer
The invention relates to a method of treating cancer, comprising administering to a subject in need thereof an effective amount of a HSV-2 virus, wherein the virus lacks protein kinase activity of... |
|
|
US20100297081 |
PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN
The present invention provides a pharmaceutical formulation containing a recombinant human serum albumin-interferon α fusion protein (rHSA-IFNα), said formulation is prepared by dissolving the... |
|
|
US20130129680 |
METHOD FOR TREATING HEPATITIS C VIRUS INFECTION USING QUERCETIN-CONTAINING COMPOSITIONS
A method for treating hepatitis C virus infection with a composition containing quercetin, together with one or more of vitamin B3, vitamin C, a folate compound. Also disclosed is a method for... |
|
|
US20140030226 |
PREVENTION AND TREATMENT OF OCULAR SIDE EFFECTS WITH A CYCLOSPORIN
Therapeutic methods are disclosed herein. |